Magle Chemoswed Holding Ab Asset Resilience Ratio
Magle Chemoswed Holding Ab asset resilience ratio. Magle Chemoswed Holding Ab (MAGLE) has an Asset Resilience Ratio of 0.02% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Magle Chemoswed Holding Ab defensive liquidity buffer to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Magle Chemoswed Holding Ab (2017–2023)
Asset resilience ratio of Magle Chemoswed Holding Ab from 2017 to 2023. This chart shows how Magle Chemoswed Holding Ab's Asset Resilience Ratio has changed over time. Read debt load of Magle Chemoswed Holding Ab for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Magle Chemoswed Holding Ab's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Magle Chemoswed Holding Ab assets under control.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr0.00 | 0% |
| Short-term Investments | Skr56.00K | 0.02% |
| Total Liquid Assets | Skr56.00K | 0.02% |
Asset Resilience Insights
- Limited Liquidity: Magle Chemoswed Holding Ab maintains only 0.02% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Magle Chemoswed Holding Ab Industry Peers by Asset Resilience Ratio
Compare Magle Chemoswed Holding Ab's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
Biotechnology | 62.31% |
|
Verona Pharma plc
F:I9SA |
Biotechnology | 0.00% |
|
Centessa Pharmaceuticals PLC ADR
NASDAQ:CNTA |
Biotechnology | 33.37% |
|
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
Biotechnology | 2.03% |
|
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
Biotechnology | 8.08% |
|
Bavarian Nordic
CO:BAVA |
Biotechnology | 10.83% |
|
Hebei Changshan Biochem Pharma
SHE:300255 |
Biotechnology | -0.03% |
|
Tibet Cheezheng Tibetan Medicine Co Ltd
SHE:002287 |
Biotechnology | 37.31% |
Magle Chemoswed Holding Ab Asset Resilience Ratio by Year (2017–2023)
Magle Chemoswed Holding Ab asset resilience ratio by year from 2017 to 2023. The table below shows the annual Asset Resilience Ratio data for Magle Chemoswed Holding Ab.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | 0.02% | Skr56.00K ≈ $6.03K |
Skr272.97 Million ≈ $29.38 Million |
+0.24pp |
| 2022-12-31 | -0.22% | Skr-566.00K ≈ $-60.91K |
Skr252.86 Million ≈ $27.21 Million |
+0.01pp |
| 2021-12-31 | -0.24% | Skr-566.00K ≈ $-60.91K |
Skr237.18 Million ≈ $25.52 Million |
-0.29pp |
| 2018-12-31 | 0.05% | Skr75.00K ≈ $8.07K |
Skr152.54 Million ≈ $16.42 Million |
-0.01pp |
| 2017-12-31 | 0.06% | Skr89.00K ≈ $9.58K |
Skr147.88 Million ≈ $15.91 Million |
-- |
About Magle Chemoswed Holding Ab
Magle Chemoswed Holding AB (publ), together with its subsidiaries, engages in research and development of pharmaceutical and medical device products in Sweden. It provides warfarin sodium products used as anticoagulants for multiple indications; melperone hydrochloride, which is an antipsychotic agent; isradipine, a calcium channel blocker used to treat hypertension; and benserazide hydrochloride… Read more